| pubmed-article:17901953 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17901953 | lifeskim:mentions | umls-concept:C0013216 | lld:lifeskim |
| pubmed-article:17901953 | lifeskim:mentions | umls-concept:C0278996 | lld:lifeskim |
| pubmed-article:17901953 | lifeskim:mentions | umls-concept:C0034656 | lld:lifeskim |
| pubmed-article:17901953 | lifeskim:mentions | umls-concept:C0221910 | lld:lifeskim |
| pubmed-article:17901953 | lifeskim:mentions | umls-concept:C0008838 | lld:lifeskim |
| pubmed-article:17901953 | lifeskim:mentions | umls-concept:C0016360 | lld:lifeskim |
| pubmed-article:17901953 | lifeskim:mentions | umls-concept:C0078257 | lld:lifeskim |
| pubmed-article:17901953 | lifeskim:mentions | umls-concept:C1517927 | lld:lifeskim |
| pubmed-article:17901953 | lifeskim:mentions | umls-concept:C0282460 | lld:lifeskim |
| pubmed-article:17901953 | lifeskim:mentions | umls-concept:C1446539 | lld:lifeskim |
| pubmed-article:17901953 | lifeskim:mentions | umls-concept:C0444889 | lld:lifeskim |
| pubmed-article:17901953 | lifeskim:mentions | umls-concept:C0205263 | lld:lifeskim |
| pubmed-article:17901953 | lifeskim:mentions | umls-concept:C0205179 | lld:lifeskim |
| pubmed-article:17901953 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:17901953 | pubmed:dateCreated | 2008-5-14 | lld:pubmed |
| pubmed-article:17901953 | pubmed:abstractText | We conducted a multicentric randomized phase II trial comparing 5-FU continuous infusion (PF) and cisplatin, UFT and vinorelbine (UFTVP) as induction chemotherapy (IC) in locally advanced squamous cell head and neck cancer (LA-SCHNC). Primary objective was complete response (CR) to IC and overall survival (OS) was a secondary objective. | lld:pubmed |
| pubmed-article:17901953 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17901953 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17901953 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17901953 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17901953 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17901953 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17901953 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17901953 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17901953 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17901953 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17901953 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:17901953 | pubmed:issn | 0344-5704 | lld:pubmed |
| pubmed-article:17901953 | pubmed:author | pubmed-author:MayorgaMartaM | lld:pubmed |
| pubmed-article:17901953 | pubmed:author | pubmed-author:IslaDoloresD | lld:pubmed |
| pubmed-article:17901953 | pubmed:author | pubmed-author:RiveraFernand... | lld:pubmed |
| pubmed-article:17901953 | pubmed:author | pubmed-author:Sanz-OrtizJai... | lld:pubmed |
| pubmed-article:17901953 | pubmed:author | pubmed-author:GaldósPiedadP | lld:pubmed |
| pubmed-article:17901953 | pubmed:author | pubmed-author:RubioAntonioA | lld:pubmed |
| pubmed-article:17901953 | pubmed:author | pubmed-author:RamaJulioJ | lld:pubmed |
| pubmed-article:17901953 | pubmed:author | pubmed-author:Saiz-Bustillo... | lld:pubmed |
| pubmed-article:17901953 | pubmed:author | pubmed-author:López-BreaMar... | lld:pubmed |
| pubmed-article:17901953 | pubmed:author | pubmed-author:MayordomoJose... | lld:pubmed |
| pubmed-article:17901953 | pubmed:author | pubmed-author:Vega-Villegas... | lld:pubmed |
| pubmed-article:17901953 | pubmed:author | pubmed-author:Del... | lld:pubmed |
| pubmed-article:17901953 | pubmed:author | pubmed-author:García-ReijaF... | lld:pubmed |
| pubmed-article:17901953 | pubmed:author | pubmed-author:García-Montes... | lld:pubmed |
| pubmed-article:17901953 | pubmed:author | pubmed-author:Rodríguez-Igl... | lld:pubmed |
| pubmed-article:17901953 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17901953 | pubmed:volume | 62 | lld:pubmed |
| pubmed-article:17901953 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17901953 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17901953 | pubmed:pagination | 253-61 | lld:pubmed |
| pubmed-article:17901953 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
| pubmed-article:17901953 | pubmed:meshHeading | pubmed-meshheading:17901953... | lld:pubmed |
| pubmed-article:17901953 | pubmed:meshHeading | pubmed-meshheading:17901953... | lld:pubmed |
| pubmed-article:17901953 | pubmed:meshHeading | pubmed-meshheading:17901953... | lld:pubmed |
| pubmed-article:17901953 | pubmed:meshHeading | pubmed-meshheading:17901953... | lld:pubmed |
| pubmed-article:17901953 | pubmed:meshHeading | pubmed-meshheading:17901953... | lld:pubmed |
| pubmed-article:17901953 | pubmed:meshHeading | pubmed-meshheading:17901953... | lld:pubmed |
| pubmed-article:17901953 | pubmed:meshHeading | pubmed-meshheading:17901953... | lld:pubmed |
| pubmed-article:17901953 | pubmed:meshHeading | pubmed-meshheading:17901953... | lld:pubmed |
| pubmed-article:17901953 | pubmed:meshHeading | pubmed-meshheading:17901953... | lld:pubmed |
| pubmed-article:17901953 | pubmed:meshHeading | pubmed-meshheading:17901953... | lld:pubmed |
| pubmed-article:17901953 | pubmed:meshHeading | pubmed-meshheading:17901953... | lld:pubmed |
| pubmed-article:17901953 | pubmed:meshHeading | pubmed-meshheading:17901953... | lld:pubmed |
| pubmed-article:17901953 | pubmed:meshHeading | pubmed-meshheading:17901953... | lld:pubmed |
| pubmed-article:17901953 | pubmed:meshHeading | pubmed-meshheading:17901953... | lld:pubmed |
| pubmed-article:17901953 | pubmed:year | 2008 | lld:pubmed |
| pubmed-article:17901953 | pubmed:articleTitle | Randomized phase II study of cisplatin and 5-FU continuous infusion (PF) versus cisplatin, UFT and vinorelbine (UFTVP) as induction chemotherapy in locally advanced squamous cell head and neck cancer (LA-SCHNC). | lld:pubmed |
| pubmed-article:17901953 | pubmed:affiliation | Department of Medical Oncology, Hospital Universitario Marqués de Valdecilla, 39008, Santander, Spain. oncrhf@humv.es | lld:pubmed |
| pubmed-article:17901953 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17901953 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:17901953 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:17901953 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
